MHA Statement on the Institute for Clinical and Economic Review’s Final Report on Tardive Dyskinesia
Mental Health America (MHA) congratulates the Institute for Clinical and Economic Review (ICER) on the release of its final report, Vesicular Monoamine Transporter 2 Inhibitors for Tardive Dyskinesia: Effectiveness and Value, and thanks ICER for…Read More
MHA Statement on Revisions to 42 CFR Pt II
Mental Health America (MHA) applauds the Substance Abuse and Mental Health Services Administration (SAMHSA) for updating and considering further revisions to the patient confidentiality rule 42 CFR Pt II in…Read More